𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Detection of response-predicting mutations in the kinase domain of the epidermal growth factor receptor gene in cholangiocarcinomas

✍ Scribed by G. -Y. Gwak; J. -H. Yoon; C. M. Shin; Y. J. Ahn; J. K. Chung; Y. A. Kim; T. -Y. Kim; H. -S. Lee


Publisher
Springer-Verlag
Year
2005
Tongue
English
Weight
179 KB
Volume
131
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Epidermal growth factor receptor mutatio
✍ Victor Cohen; Jason S. Agulnik; Celina Ang; Goulnar Kasymjanova; Gerald Batist; πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 206 KB πŸ‘ 1 views

## Abstract ## BACKGROUND: Somatic mutations in the epidermal growth factor receptor (EGFR) kinase domain are associated with sensitivity to EGFR‐tyrosine kinase inhibitors (EGFR‐TKI) in patients with nonsmall cell lung cancer (NSCLC). ## METHODS: The authors tested the possibility that nucleoti

Detection of epidermal growth factor rec
✍ Jin-Hyuk Choi; Jee Young Oh; Sung Ki Ryu; Seung Jung Kim; Na Young Lee; Young Su πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 79 KB πŸ‘ 2 views

malignancies including carcinoma of the breast, lung, esophagus, cervix, and stomach. In patients with gastric carcinoma, its overexpression may be associated with

Denaturing capillary electrophoresis for
✍ Lucie Benesova; Milos Pesek; Barbora Belsanova; Patrik Sekerka; Marek Minarik πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 249 KB

## Abstract The presence of activating mutations within the tyrosine kinase domain of the epidermal growth factor receptor gene has been attributed to a positive response to biological therapy of lung cancer by small‐molecular tyrosine kinase inhibitors, gefitinib and erlotinib. Among the two most